Literature DB >> 24817692

DNMT3a epigenetic program regulates the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia.

Gabriel Lachance1, James Uniacke1, Timothy E Audas1, Chet E Holterman1, Aleksandra Franovic1, Josianne Payette1, Stephen Lee2.   

Abstract

Epigenetic regulation of gene expression by DNA methylation plays a central role in the maintenance of cellular homeostasis. Here we present evidence implicating the DNA methylation program in the regulation of hypoxia-inducible factor (HIF) oxygen-sensing machinery and hypoxic cell metabolism. We show that DNA methyltransferase 3a (DNMT3a) methylates and silences the HIF-2α gene (EPAS1) in differentiated cells. Epigenetic silencing of EPAS1 prevents activation of the HIF-2α gene program associated with hypoxic cell growth, thereby limiting the proliferative capacity of adult cells under low oxygen tension. Naturally occurring defects in DNMT3a, observed in primary tumors and malignant cells, cause the unscheduled activation of EPAS1 in early dysplastic foci. This enables incipient cancer cells to exploit the HIF-2α pathway in the hypoxic tumor microenvironment necessary for the formation of cellular masses larger than the oxygen diffusion limit. Reintroduction of DNMT3a in DNMT3a-defective cells restores EPAS1 epigenetic silencing, prevents hypoxic cell growth, and suppresses tumorigenesis. These data support a tumor-suppressive role for DNMT3a as an epigenetic regulator of the HIF-2α oxygen-sensing pathway and the cellular response to hypoxia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24817692      PMCID: PMC4040594          DOI: 10.1073/pnas.1322909111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

3.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  DNMT3A mutations in acute myeloid leukemia.

Authors:  Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson
Journal:  N Engl J Med       Date:  2010-11-10       Impact factor: 91.245

5.  HIF-2alpha deletion promotes Kras-driven lung tumor development.

Authors:  Jolly Mazumdar; Michele M Hickey; Dhruv K Pant; Amy C Durham; Alejandro Sweet-Cordero; Anil Vachani; Tyler Jacks; Lewis A Chodosh; Joseph L Kissil; M Celeste Simon; Brian Keith
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-21       Impact factor: 11.205

6.  Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers.

Authors:  Min S Kim; Yoo R Kim; Nam J Yoo; Sug H Lee
Journal:  APMIS       Date:  2012-07-03       Impact factor: 3.205

7.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

8.  Regulation of endocytosis via the oxygen-sensing pathway.

Authors:  Yi Wang; Olga Roche; Mathew S Yan; Greg Finak; Andrew J Evans; Julie L Metcalf; Bridgid E Hast; Sara C Hanna; Bill Wondergem; Kyle A Furge; Meredith S Irwin; William Y Kim; Bin T Teh; Sergio Grinstein; Morag Park; Philip A Marsden; Michael Ohh
Journal:  Nat Med       Date:  2009-03-01       Impact factor: 53.440

9.  Identification of preferential target sites for human DNA methyltransferases.

Authors:  Si Ho Choi; Kyu Heo; Hyang-Min Byun; Woojin An; Wange Lu; Allen S Yang
Journal:  Nucleic Acids Res       Date:  2010-09-13       Impact factor: 16.971

10.  Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.

Authors:  Sakari Vanharanta; Weiping Shu; Fabienne Brenet; A Ari Hakimi; Adriana Heguy; Agnes Viale; Victor E Reuter; James J-D Hsieh; Joseph M Scandura; Joan Massagué
Journal:  Nat Med       Date:  2012-12-09       Impact factor: 53.440

View more
  22 in total

Review 1.  Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer.

Authors:  Johannes Schödel; Steffen Grampp; Eamonn R Maher; Holger Moch; Peter J Ratcliffe; Paul Russo; David R Mole
Journal:  Eur Urol       Date:  2015-08-19       Impact factor: 20.096

2.  The fat cell epigenetic signature in post-obese women is characterized by global hypomethylation and differential DNA methylation of adipogenesis genes.

Authors:  I Dahlman; I Sinha; H Gao; D Brodin; A Thorell; M Rydén; D P Andersson; J Henriksson; A Perfilyev; C Ling; K Dahlman-Wright; P Arner
Journal:  Int J Obes (Lond)       Date:  2015-03-18       Impact factor: 5.095

Review 3.  Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-α protein stability and activity.

Authors:  Weibo Luo; Yingfei Wang
Journal:  Cell Mol Life Sci       Date:  2017-10-14       Impact factor: 9.261

Review 4.  Epigenetic changes by DNA methylation in chronic and intermittent hypoxia.

Authors:  Jayasri Nanduri; Gregg L Semenza; Nanduri R Prabhakar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

Review 5.  Epigenomics and human adaptation to high altitude.

Authors:  Colleen G Julian
Journal:  J Appl Physiol (1985)       Date:  2017-08-17

6.  Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes.

Authors:  Xiefan Fang; Ryan R Poulsen; John Wang-Hu; Olivia Shi; Nicholas S Calvo; Chelsey S Simmons; Scott A Rivkees; Christopher C Wendler
Journal:  FASEB J       Date:  2016-06-15       Impact factor: 5.191

7.  MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.

Authors:  Jie Cui; Biao Duan; Xuyang Zhao; Yan Chen; Shixun Sun; Wenjie Deng; Yujie Zhang; Jun Du; Yongchang Chen; Luo Gu
Journal:  Tumour Biol       Date:  2016-07-27

Review 8.  Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia.

Authors:  Shaliny Ramachandran; Jonathan Ient; Eva-Leonne Göttgens; Adam J Krieg; Ester M Hammond
Journal:  Genes (Basel)       Date:  2015-09-25       Impact factor: 4.096

9.  Importance of rare gene copy number alterations for personalized tumor characterization and survival analysis.

Authors:  Michael Seifert; Betty Friedrich; Andreas Beyer
Journal:  Genome Biol       Date:  2016-10-03       Impact factor: 13.583

10.  Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.

Authors:  Michael S Nakazawa; T S Karin Eisinger-Mathason; Navid Sadri; Joshua D Ochocki; Terence P F Gade; Ruchi K Amin; M Celeste Simon
Journal:  Nat Commun       Date:  2016-02-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.